Showing results (111-120 of 2,957) with videos related to

Sort By:
Pageof 296
Molecular Medicine (Cambridge, Mass.)|April 5, 2013
Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)Mårten Wendt, Ola Börjesson, Aune Avik, et al.
Molecular Medicine (Cambridge, Mass.)|April 5, 2013
MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosisXiao Wang, Heng-Fu Bu, Wei Zhong, et al.
Molecular Medicine (Cambridge, Mass.)|May 15, 2013
Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cellsDana Marcus, Michal Lichtenstein, Ann Saada, et al.
Molecular Medicine (Cambridge, Mass.)|May 11, 2012
Hyperglycemia exacerbates burn-induced liver inflammation via noncanonical nuclear factor-κB pathway activationGabriela A Kulp, Ronald G Tilton, David N Herndon, et al.
Molecular Medicine (Cambridge, Mass.)|May 3, 2012
MGMT inhibition restores ERα functional sensitivity to antiestrogen therapyGeorge C Bobustuc, Joshua S Smith, Sreeram Maddipatla, et al.
Molecular Medicine (Cambridge, Mass.)|October 5, 2013
Activation of AMPK enhances neutrophil chemotaxis and bacterial killingDae Won Park, Shaoning Jiang, Jean-Marc Tadie, et al.
Molecular Medicine (Cambridge, Mass.)|May 2, 2002
Influenza virus infection is not affected by serum amyloid P componentJeff Herbert, Winston L Hutchinson, Jackie Carr, et al.
Molecular Medicine (Cambridge, Mass.)|March 6, 2002
COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cellsK Meyer-Siegler
Molecular Medicine (Cambridge, Mass.)|May 1, 1997
Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa BS V Spitsin, J L Farber, M Bertovich, et al.
Molecular Medicine (Cambridge, Mass.)|December 1, 2009
Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancerStephanie L Nott, Yanfang Huang, Aja Kalkanoglu, et al.
Pageof 296